Showing 651-660 of 2448 results for "".
Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/Comprehensive Stroke Certification What Does Does it Take?
https://practicalneurology.com/diseases-diagnoses/stroke/comprehensive-stroke-certification-what-does-does-it-take/30704/The Ochsner Medical Center ExperienceTics and Tourette Syndrome
https://practicalneurology.com/diseases-diagnoses/child-neurology/tics-and-tourette-syndrome/30330/Recognizing the full spectrum of phenomenology of tics and various behavioral comorbidities is critical to diagnosis.A Survey of Neurologists on Career Satisfaction and Burnout
https://practicalneurology.com/columns/practice-management/a-survey-of-neurologists-on-career-satisfaction-and-burnout/30707/Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-in-the-preventive-treatment-of-chronic-migraine-and-other-headaches/30833/While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.The Health Care Debate: What Will It Mean For You?
https://practicalneurology.com/columns/practice-management/PN0909_01-php/30887/The changes proposed in Congress could mean big changes to your practice. We take a look at how things could play out.COVID-19 & Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/covid-19-stroke/31740/COVID-19 has brought significant changes in stroke presentations, systems of care, and resource availability.Movement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c